|
|||||
|
|
Conventional Understanding of SARS-CoV-2 Mpro and Common Strategies for Developing Its Inhibitors |
|
| Authors: | Kun Zhou Dr Daquan Chen |
| Affiliation: | School of Pharmacy, Yantai University, Yantai, Shandong, RT 264005 P.?R. China |
| Abstract: | |
| Keywords: | COVID-19 drug design Mpro peptidomimetic inhibitors SARS-CoV-2 |